Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinji Hatakeyama

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
BMC Research Notes|July 17, 2019
A novel tissue-selective β2-adrenoceptor agonist with minimized cardiovascular effects, 5-HOB, attenuates neuropathic pain in miceMarie Jourdain, Shinji Hatakeyama
Biochemical and Biophysical Research Communications|July 4, 2018
Mouse models of cancer-induced cachexia: Hind limb muscle mass and evoked force as readoutsMarie Jourdain, Stefan Melly, Serge Summermatter, et al.
Prostaglandins & Other Lipid Mediators|February 20, 2008
Group IVA phospholipase A2 is associated with the storage of lipids in adipose tissue and liverHiromi Ii, Shinji Hatakeyama, Kae Tsutsumi, et al.
Heliyon|November 27, 2019
Identification and characterization of a phenyl-thiazolyl-benzoic acid derivative as a novel RAR/RXR agonistChie Koshiishi, Takanori Kanazawa, Eric Vangrevelinghe, et al.
BMC Research Notes|April 4, 2019
Evaluation of therapeutic effects of FAK inhibition in murine models of atherosclerosisTakeshi Yamaura, Tatsuhiko Kasaoka, Naoko Iijima, et al.
FEBS Letters|June 5, 2002
Variant forms of upstream stimulatory factors (USFs) control the promoter activity of hTERT, the human gene encoding the catalytic subunit of telomeraseMasako Yago, Rieko Ohki, Shinji Hatakeyama, et al.
BMC Research Notes|June 20, 2019
Pharmacological profiling of a dual FAK/IGF-1R kinase inhibitor TAE226 in cellular and in vivo tumor modelsShigemi Fukami, Daisaku Tomioka, Yutaka Murakami, et al.
Skeletal Muscle|July 28, 2016
ActRII blockade protects mice from cancer cachexia and prolongs survival in the presence of anti-cancer treatmentsShinji Hatakeyama, Serge Summermatter, Marie Jourdain, et al.
American Journal of Physiology. Cell Physiology|April 10, 2009
Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube sizeAnne Ulrike Trendelenburg, Angelika Meyer, Daisy Rohner, et al.
Molecular Diagnosis & Therapy|January 17, 2025
Development of a New Rapid Simultaneous Molecular Assay for the Detection of STI Pathogens and Drug Resistance-Associated MutationsMasashi Michibuchi, Takafumi Yoshikane, Yuma Matsuba, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
BMC Research Notes|July 17, 2019
A novel tissue-selective β2-adrenoceptor agonist with minimized cardiovascular effects, 5-HOB, attenuates neuropathic pain in miceMarie Jourdain, Shinji Hatakeyama
Biochemical and Biophysical Research Communications|July 4, 2018
Mouse models of cancer-induced cachexia: Hind limb muscle mass and evoked force as readoutsMarie Jourdain, Stefan Melly, Serge Summermatter, et al.
Prostaglandins & Other Lipid Mediators|February 20, 2008
Group IVA phospholipase A2 is associated with the storage of lipids in adipose tissue and liverHiromi Ii, Shinji Hatakeyama, Kae Tsutsumi, et al.
Heliyon|November 27, 2019
Identification and characterization of a phenyl-thiazolyl-benzoic acid derivative as a novel RAR/RXR agonistChie Koshiishi, Takanori Kanazawa, Eric Vangrevelinghe, et al.
BMC Research Notes|April 4, 2019
Evaluation of therapeutic effects of FAK inhibition in murine models of atherosclerosisTakeshi Yamaura, Tatsuhiko Kasaoka, Naoko Iijima, et al.
FEBS Letters|June 5, 2002
Variant forms of upstream stimulatory factors (USFs) control the promoter activity of hTERT, the human gene encoding the catalytic subunit of telomeraseMasako Yago, Rieko Ohki, Shinji Hatakeyama, et al.
BMC Research Notes|June 20, 2019
Pharmacological profiling of a dual FAK/IGF-1R kinase inhibitor TAE226 in cellular and in vivo tumor modelsShigemi Fukami, Daisaku Tomioka, Yutaka Murakami, et al.
Skeletal Muscle|July 28, 2016
ActRII blockade protects mice from cancer cachexia and prolongs survival in the presence of anti-cancer treatmentsShinji Hatakeyama, Serge Summermatter, Marie Jourdain, et al.
American Journal of Physiology. Cell Physiology|April 10, 2009
Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube sizeAnne Ulrike Trendelenburg, Angelika Meyer, Daisy Rohner, et al.
Molecular Diagnosis & Therapy|January 17, 2025
Development of a New Rapid Simultaneous Molecular Assay for the Detection of STI Pathogens and Drug Resistance-Associated MutationsMasashi Michibuchi, Takafumi Yoshikane, Yuma Matsuba, et al.
Pageof 4